Delivery from RISE – Lumito proceeds to make optimizations on its own account
On behalf of Lumito, RISE has developed protocols for development of reagents for tissue staining based on UCNPs (UpConverting NanoParticles). The stained tissue samples are scanned with Lumitos scanner to obtain high-contrast imaging without background information. RISE delivered the results of the development effort at the end of June. During spring, Lumito has established a laboratory […]
Lumitos latest presentation and podcast
Stefan Nilsson, the CEO of Lumito, presents the company in Småbolagspodden today and in Aktiedagen yesterday. Both presentations are now available in Swedish at https://lumito.se/presentationer/. Enjoy! Best regards, The Lumito Team For further information, please contact Stefan Nilsson, CEO of Lumito Telephone: +4676-778 59 05 E-mail:sn@lumito.se Latest podcast and presentation
The instrument is to be delivered in June
Lumito's development partner TTP in Cambridge has informed that Lumito's instrument intended for validation in reference clinics is projected to be delivered in June, which is 6-8 weeks later than planned. The reason for the delay is the ongoing coronavirus pandemic and the fact that the UK has been in a state of lockdown for […]
Patent approved on the Korean market for tissue diagnostics. The patent is previously approved in Australia, China, South Africa, the US and Japan
Lumito's product offering comprises an instrument and staining reagents based on UCNPs (upconverting nanoparticles). The instrument is used to provide pathologists and biomedical analysts visual depictions of tissue samples as an input for making diagnosis. The tissue samples are stained using specific reagents to create imaging with higher contrast and thus improve the chance of […]
Status update regarding the completion of Lumito’s first product
The development of Lumito’s first product (instrument + staining reagent) in digital tissue diagnostics, for analyzing tissue sections stained with the company’s nano-based staining reagents, is entering its final stage prior to launch. The development of the actual instrument is proceeding according to plan, and the first instruments, which are intended for customer validation at […]
First exercise window for Lumito warrants closes
On 29 November, Lumito AB (publ) (“Lumito”) ended the first exercise period for the Series 2 TO2 subscription warrant. The exercise rate was 72.3 percent, at an exercise price of SEK 1.45 per share. In total, 11,179,281 new shares have been subscribed during the now concluded first exercise period. Lumito is thus provided approximately MSEK […]
Lumito – winner in the poster competition and awarded with a presentation at the Digital Pathology & AI Congress in London
Lumito has been selected by the conference committee as the winner of the poster competition and has been awarded a 15 min presentation at the Digital Pathology & AI Congress in London on 5-6 December. Lumito will be presented to over 420 attendees and 35 exhibitors at the sold out meeting. Krzysztof Krawczyk, R&D Manager […]
Important progress in product development – simultaneous staining in the same section, with high degree of detail
Lumito is developing a novel method for high-contrast imaging without background signal. The first application is developed for tissue diagnostics and digital pathology. In order to visualize cells containing Her2, which is a common marker in breast cancer diagnostics, Lumito is now presenting new images of breast tissues stained with the Company's Her2-UCNP reagent. Lumito's […]
The alpha prototype of the instrument delivered to Lumito according to plan
Lumito’s development partner TTP has delivered the alpha prototype of what will be Lumito’s first product. After delivery, the instrument has successfully undergone internal acceptance testing. The ongoing development phase of Lumito’s first product includes the development of an alpha prototype, with essential functionality implemented (“work like”), and thereafter a beta prototype, with complete implementation […]
Lumito – the first results from the new instrument prototype – significantly improved image quality.
Based on the results obtained from the concept phase, the new instrument prototype has been developed. Comparison made using the same microscope slides as the ones used in the concept phase with Lumito’s staining reagent shows significantly improved image quality. After the concept phase was completed during Q4 2018, phase two of the instrument and […]
